Notuminhibitors can restore Wnt signaling which may be of therapeutic benefitfor pathologies such as osteoporosis and Alzheimer’s disease.We report the identification of a novel class of covalent Notum inhibitors,4-(indolin-1-yl)-4-oxobutanoate esters. This evidence concerns the gene NOTUM and early-onset autosomal dominant Alzheimer disease.